569 related articles for article (PubMed ID: 10606305)
21. Increased prevalence of Helicobacter pylori infection in gastric cardia of patients with reflux esophagitis: a study from Jordan.
Abdul-Razzak KK; Bani-Hani KE
J Dig Dis; 2007 Nov; 8(4):203-6. PubMed ID: 17970877
[TBL] [Abstract][Full Text] [Related]
22. Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis.
Chen YY; Antonioli DA; Spechler SJ; Zeroogian JM; Goyal RK; Wang HH
Mod Pathol; 1998 Oct; 11(10):950-6. PubMed ID: 9796721
[TBL] [Abstract][Full Text] [Related]
23. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
24. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
25. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer.
Sakaki N; Momma K; Egawa N; Yamada Y; Kan T; Ishiwata J
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S59-62. PubMed ID: 8574738
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease.
Weck MN; Gao L; Brenner H
Epidemiology; 2009 Jul; 20(4):569-74. PubMed ID: 19404195
[TBL] [Abstract][Full Text] [Related]
27. Relationship between Helicobacter pylori and atrophic gastritis.
Satoh K; Kimura K; Yoshida Y; Ota Y; Taniguchi Y; Kihira K; Kasano T; Takimoto T; Suzuki T; Seki M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S85-8. PubMed ID: 7735942
[TBL] [Abstract][Full Text] [Related]
28. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis.
Sudraba A; Daugule I; Rudzite D; Funka K; Tolmanis I; Engstrand L; Janciauskas D; Jonaitis L; Kiudelis G; Kupcinskas L; Ivanauskas A; Leja M
J Gastrointestin Liver Dis; 2011 Dec; 20(4):349-54. PubMed ID: 22187698
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection.
Hahn M; Fennerty MB; Corless CL; Magaret N; Lieberman DA; Faigel DO
Gastrointest Endosc; 2000 Jul; 52(1):20-6. PubMed ID: 10882957
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection is the major risk factor for atrophic gastritis.
Kawaguchi H; Haruma K; Komoto K; Yoshihara M; Sumii K; Kajiyama G
Am J Gastroenterol; 1996 May; 91(5):959-62. PubMed ID: 8633588
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
32. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive, and babA2-positive genotype in erosive reflux esophagitis disease.
Lai CH; Poon SK; Chen YC; Chang CS; Wang WC
Helicobacter; 2005 Dec; 10(6):577-85. PubMed ID: 16302983
[TBL] [Abstract][Full Text] [Related]
33. [The prevalence of atrophic gastritis and intestinal metaplasia according to gender, age and Helicobacter pylori infection in a rural population].
Kim HJ; Choi BY; Byun TJ; Eun CS; Song KS; Kim YS; Han DS
J Prev Med Public Health; 2008 Nov; 41(6):373-9. PubMed ID: 19037166
[TBL] [Abstract][Full Text] [Related]
34. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
Leri O; Mastropasqua M; Scopelliti G; Grasso E; Losi T; Iadicicco A; Perinelli P
Clin Ter; 1999; 150(5):343-6. PubMed ID: 10687264
[TBL] [Abstract][Full Text] [Related]
35. The pathology of gastric cardia: a prospective, endoscopic, and morphologic study.
Cestari R; Villanacci V; Bassotti G; Rossi E; Casa DD; Missale G; Minelli L; Cengia P; Gambarotti M; Pirali F; Donato F; Genta RM
Am J Surg Pathol; 2007 May; 31(5):706-10. PubMed ID: 17460453
[TBL] [Abstract][Full Text] [Related]
36. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries.
De Vries AC; Van Driel HF; Richardus JH; Ouwendijk M; Van Vuuren AJ; De Man RA; Kuipers EJ
Scand J Gastroenterol; 2008; 43(4):403-9. PubMed ID: 18365904
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
[TBL] [Abstract][Full Text] [Related]
38. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis.
Satoh K; Kimura K; Taniguchi Y; Kihira K; Takimoto T; Saifuku K; Kawata H; Tokumaru K; Kojima T; Seki M; Ido K; Fujioka T
Am J Gastroenterol; 1998 Apr; 93(4):569-73. PubMed ID: 9576449
[TBL] [Abstract][Full Text] [Related]
39. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
40. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
